Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
B Têtu , Y Fradet , P Allard , P Bernard
Clinical Cancer Research 1 ( 10) 1195 -1202
48
1995
Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines
J Bellemare , M Rouleau , M Harvey , B Têtu
Pharmacogenomics Journal 10 ( 5) 431 -441
26
2010
Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
H Raybaud-Diogène , A Fortin , R Morency , J Roy
Journal of Clinical Oncology 15 ( 3) 1030 -1038
124
1997
p53 is associated with radioresistance in head and neck carcinomas treated by radical radiotherapy
A Fortin , C Couture , B Têtu , R Doucet
International Journal of Radiation Oncology Biology Physics 48 ( 3) 262
2000
Prévention des seconds cancers primaires par supplémentation vitaminique chez les patients traités pour un cancer ORL
I Bairati , F Brochet , J Roy , M Gélinas
Bulletin du Cancer/Radiothérapie 83 ( 1) 12 -16
5
1996
Incidence et facteurs de risque de seconds cancers primaires chez les patients traités pour un premier cancer du pharynx
F Brochet , I Bairati , J Roy , M Gélinas
Bulletin du Cancer/Radiothérapie 83 ( 1) 8 -11
1
1996
Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease
L Florianova , M Orain , B Têtu , CJ Doillon
Biotechnic & Histochemistry 88 ( 5) 222 -234
1
2013
Author Index Vol. 35, No. 5–6, 1999
Peter Ekman , Yves Fradet , François Meyer , Isabelle Bairati
European Urology 35 ( 5-6) 548 -548
1999
Contents Vol. 35, No. 5–6, 1999
Peter Ekman , Yves Fradet , François Meyer , Isabelle Bairati
European Urology 35 ( 5-6) 337 -340
1999
Prostatitis and Urethritis
Peter Ekman , Yves Fradet , François Meyer , Isabelle Bairati
European Urology 35 ( 5-6) 557 -566
1999
Abstraits AUQ 2018
A Rompré-Brodeur , M Ayoub , S Shinde , C Piccirilo
Canadian Urological Association Journal= Journal de L'association des Urologues du Canada 12 ( 10Suppl5) S257 -S270
2018
Symposium 23B: Molecular diagnosis of bladder cancer.
MA Knowles , B Têtu , R Tiguert , V Bernier
Histopathology 41
2002
Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer.
W Hanna , FP O’malley , P Barnes , R Berendt
Current Oncology 14 ( 4) 149 -153
57
2007
Morphologic effects of neoadjuvant hormone therapy on prostate cancer
B Têtu , TH Van der Kwast , Y Fradet , B Candas
MOLECULAR UROLOGY 2 ( 3) 103 -107
2
1998
An international university network for online teaching of pathology in Frenchspeaking countries
P Bertheau , E Perron , M Battistella , B Vergier
12th European Congress on Digital Pathology
2014
Morphologic changes induced by neoadjuvant combination hormone therapy on prostatic tissue and prostate cancer
B Têtu
Endocrine-related Cancer 3 ( 3) 165 -170
4
1996
Guidelines for Establishing a Telepathology Service for Anatomic Pathology Using Whole Slide Imaging
B Têtu , Canadian Association of Pathologists Telepathology Committee
Canadian Association of Pathologists Canada
2
2012
A biopsy-driven and biomarker discovery clinical trial in metastatic colorectal cancer led by a new Quebec-wide translational research network, to identify signatures of clinical resistance
G Batist , P Kavan , M Orain , E Camlioglu
ANNALS OF ONCOLOGY 21 70 -70
2
2010
Résumés sélectionnés de posters et publications du Congrès annuel de l’Association des pathologistes du Québec—25 et 26 avril 2009, Montréal
J Chênevert , M Plante , M Roy , B Têtu
Annales de pathologie 29 453 -456
2009
Technology & tools development
E Pefani , N Panoskaltsis , A Mantalaris , MC Georgiadis
Annals of Oncology 23
2012